These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 4608133)
1. Kidney disease and drug metabolism. Reidenberg MM Med Clin North Am; 1974 Sep; 58(5):1059-62. PubMed ID: 4608133 [No Abstract] [Full Text] [Related]
2. Drug metabolism in uremia. Reidenberg MM Clin Nephrol; 1975; 4(3):83-5. PubMed ID: 1102176 [No Abstract] [Full Text] [Related]
3. Hepatic drug metabolism in vitro in the horse. Yeary RA; Gerken D Biochem Pharmacol; 1971 Nov; 20(11):3219-21. PubMed ID: 5132124 [No Abstract] [Full Text] [Related]
4. Renal failure and the action of drugs. Dawborn JK Prog Biochem Pharmacol; 1974; 9():206-20. PubMed ID: 4612557 [No Abstract] [Full Text] [Related]
6. [Changes of pharmacokinetics in uremia with special reference to drug catabolism]. Leber HW Med Klin; 1976 Aug; 71(34):1321-30. PubMed ID: 785180 [No Abstract] [Full Text] [Related]
7. Procaine hydrolysis defect in uraemia does not appear to be due to carbamylation of plasma esterases. Calvo R; Carlos R; Erill S Eur J Clin Pharmacol; 1983; 24(4):533-5. PubMed ID: 6861870 [TBL] [Abstract][Full Text] [Related]
9. Influence of oral tobacco and nicotine consumption on the hydrolytic metabolism of xenobiotics. Ali B; Kaur S Biochem Pharmacol; 1982 Nov; 31(22):3683-4. PubMed ID: 7181951 [No Abstract] [Full Text] [Related]
10. Serum enzymes of drug metabolism. Williams FM Pharmacol Ther; 1987; 34(1):99-109. PubMed ID: 3310046 [No Abstract] [Full Text] [Related]
11. [Effect of renal failure on the frequency of undesirable drug effects]. Ruiz I; Naranjo CA; Campillo G Therapie; 1977; 32(3):271-8. PubMed ID: 929498 [No Abstract] [Full Text] [Related]
12. Effects of renal disease upon drug disposition. Reidenberg MM; Drayer DE Drug Metab Rev; 1978; 8(2):293-302. PubMed ID: 363386 [No Abstract] [Full Text] [Related]
14. Uremia and the liver. II. Drugs and the liver in the uremic patient. Simon P; Meyrier A; Brissot P Nephron; 1981; 29(1-2):7-13. PubMed ID: 7035980 [No Abstract] [Full Text] [Related]
15. In vitro acetylation of drugs by human blood cells. Drayer DE; Strong JM; Jones B; Sandler A; Reidenberg MM Drug Metab Dispos; 1974; 2(6):499-505. PubMed ID: 4155674 [No Abstract] [Full Text] [Related]
16. [Hydrolysis and oxidation of drugs in various fractions of liver microsomes]. REMMER H Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1960; 238():36-7. PubMed ID: 14437293 [No Abstract] [Full Text] [Related]
17. [Influence of uremia on glucuronization of drugs in rat liver microsomes]. Leber HW; Gleumes A; Schütterle G Verh Dtsch Ges Inn Med; 1973; 79():711-3. PubMed ID: 4789956 [No Abstract] [Full Text] [Related]
18. [Dosages of drugs in patients with kidney function disorders]. Verresen L Ned Tijdschr Geneeskd; 1991 Mar; 135(13):547-51. PubMed ID: 2027403 [No Abstract] [Full Text] [Related]
19. Genetically determined variability in acetylation and oxidation. Therapeutic implications. Clark DW Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977 [TBL] [Abstract][Full Text] [Related]
20. Studies of protein bound substances in uremia. Vanholder R; De Smet R; Ringoir S ASAIO J; 1994; 40(1):90-2. PubMed ID: 8186501 [No Abstract] [Full Text] [Related] [Next] [New Search]